Live News Categoriesequity

Tetratherix Limited (TTX.AX) News

Follow Tetratherix Limited (TTX.AX) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol TTX.AX Asset equity Sector Markets 90 days 1 Last 6.7 Updated Oct 05, 2026, 11:16 PM UTC Open live news feed Open TTX.AX chart & news

L Tetratherix (TTX.AX) rises on FDA update on Tegenix application Shares of Tetratherix gained as much as 5% to A$6.70, their highest level since September 23, after the medical technology company said the U.S. FDA completed an initial review of its application for Tegenix. EQUITY | Oct 05, 2026, 11:16 PM UTC